{"transactions":[{"id":2270526,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":127306,"kind":"person","name":"Fawaz Ali D.","position":1,"cik":"0001928287","reported_name":"Fawaz Ali D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-17T00:38:54.000Z","date":"2022-05-16","kind":"grant","acquired":true,"shares":361586,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option shall vest on May 16, 2023, and 1/36th of the remaining number of shares subject to the option vest monthly thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":361586,"derivative":{"exercise_price":7.68,"expiration_date":"2032-05-15","underlying":"Common Stock","underlying_shares":361586},"source":{"system":"sec-edgar","filing":"0001209191-22-029441","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919122029441/doc4.xml","form_type":"4"}},{"id":2270525,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":127306,"kind":"person","name":"Fawaz Ali D.","position":1,"cik":"0001928287","reported_name":"Fawaz Ali D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-17T00:38:54.000Z","date":"2022-05-16","kind":"grant","acquired":true,"shares":3752,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests based on achievement of a performance objective."}],"balance_after":3752,"derivative":{"exercise_price":7.68,"expiration_date":"2032-05-15","underlying":"Common Stock","underlying_shares":3752},"source":{"system":"sec-edgar","filing":"0001209191-22-029441","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919122029441/doc4.xml","form_type":"4"}},{"id":2270524,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":127306,"kind":"person","name":"Fawaz Ali D.","position":1,"cik":"0001928287","reported_name":"Fawaz Ali D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-17T00:38:54.000Z","date":"2022-05-16","kind":"grant","acquired":true,"shares":2301,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests based on achievement of a performance objective."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option shall vest on May 16, 2023, and 1/36th of the remaining number of shares subject to the option vest monthly thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":2301,"derivative":{"exercise_price":7.68,"expiration_date":"2032-05-15","underlying":"Common Stock","underlying_shares":2301},"source":{"system":"sec-edgar","filing":"0001209191-22-029441","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919122029441/doc4.xml","form_type":"4"}}]}